We are pleased to announce that Bioportugal is the partner of choice for the introduction of the new DNBSEQ TM massive sequencing technology of the MGI brand in Portugal!

MGI produces New Generation Genetic Sequencing platforms, extraction equipment, pipetting robots, consumables and reagents to support research in Life Sciences, Medicine and Health. Its proprietary DNBSEQTM technology and its “DNA NanoballsTM ” allow new applications in areas such as WES, WGS, Agrigenomics and detection and sequencing of microorganism genomes, such as SARS-CoV-2.

The presence of MGI in Portugal will serve, together with Bioportugal, to promote advanced technologies of Investigation and efficient and accessible Diagnosis in the region, including participation in Congresses and Meetings, organization of seminars in several local institutions and awareness about the platform of sequencing of MGI to support health research and applications for all types of customers and employees.

MGI, based in Shenzhen, China, has more than 1,000 sequencers installed in more than 16 countries.